BDBM727062 1-[(2S)-7-methyl-6-(2-methyl-2H-tetrazol-5-yl)-3,4-dihydro-1H-spiro[1,8-naphthyridine-2,3''-pyrrolidin]-1''-yl]-2-[4-(trifluoromethyl)phenyl]propan-1-one, DIAST-1::US20250084084, Example 109

SMILES Cc1ccc([C@@H](C)C(=O)N2CC[C@@]3(CCc4cc(-c5nnn(C)n5)c(C)nc4N3)C2)cc1

InChI Key InChIKey=HZKFLNBFZQFVHY-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 727062   

TargetMelanocortin receptor 4(Human)
Pfizer

US Patent
LigandPNGBDBM727062(1-[(2S)-7-methyl-6-(2-methyl-2H-tetrazol-5-yl)-3,4...)
Affinity DataKi:  0.730nMAssay Description:The binding affinity of test compounds at the α-melanocyte-stimulating hormone receptor (hMC4R) was assessed using a radioligand competition binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/17/2025
Entry Details
US Patent